Diabetes and Obesity

Research Overview

Diabetes and obesity are an increasing burden worldwide and are major risk factors for cardiovascular diseases. Our research focuses on type 1 and type 2 diabetes, diabetes complications and obesity. We have access to a large cohort of patients and undertake observational as well as randomised clinical studies in patients with type 1, type 2 diabetes and obesity.

Current studies include but are not limited to:

  • Detection and management of diabetes complications in particular diabetic   kidney disease;
  • Effects of dietary salt intake in diabetes;
  • Effects of pregnancy on renal function in patients with diabetes;
  • Effects of very low calorie diets on obesity in general population, in pre-pregnancy population and in geriatric population;
  • Prevalence and outcomes of inpatients with diabetes and obesity.


  • Cilla Haywood, Postdoctoral researcher
  • Jas-mine Seah, PhD student and Endocrinologist
  • Sara Baqar, PhD student and Endocrinologist
  • Mariam Hachem, Research Assistant


  • Associate Professor Sof Andrikopoulos, University of Melbourne
  • Professor Jeffrey Zajac, Head of Medicine, Austin Health
  • Professor Richard MacIsaac, Director of Diabetes at St. Vincent's Hospital, Melbourne
  • Dr Elisabeth Lambert, Senior Researcher, Swinburne University
  • Professor Leonid Churilov, Florey Institute of Neuroscience and Mental Health
  • Professor Melinda Coughlan, Senior Researcher, Monash University
  • Professor George Jerums, University of Melbourne


Some of our funding sources:

  • Sir Edward Dunlop Medical Research Foundation
  • Viertel Clinical Investigatorship
  • DART (Diabetes Australia Research Trust)
  • NHMRC (National Health and Medical Research Council) Early Career Fellowship
  • AstraZeneca Pty Ltd Project Grant
  • Stroke Foundation

Research Publications

  1. Libianto R, Moran J, O'Callaghan C, Baqar S, Chen AX, Baker ST, Clarke M, Macisaac RJ, Jerums G, Ekinci EI. Relationship between Urinary Sodium‐to‐Potassium Ratio and Ambulatory Blood Pressure in Patients with Diabetes Mellitus. Clinical and Experimental Pharmacology and Physiology. 2017 Sep 16.
  2. Weiss J, Wood A J, Zajac JD , Grossmann M, Andrikopoulos S, Ekinci EI. Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use, Diabetes Research and Clinical Practice, accepted 31st August 2017
  3. Amanda Leong; Elif I Ekinci*; Cattram Nguyen; Michele Milne; Mariam Hachem; Matthew Dobson; Richard J MacIsaac; George Jerums Long term Intra-individual Variability of Albuminuria in Type 2 Diabetes Mellitus: Implications for Categorization of Albumin Excretion Rate, BMC Nephrology, accepted 10th August 2017 * equal first author contribution
  4. Jha JC, Banal C, Okabe J, Gray SP, Hettige T, Chow BSM, Thallas-Bonke V, De Vos L, Holterman CE, Coughlan MT, Power DA, Skene A, Ekinci EI, Cooper ME, Touyz RM, Kennedy CR, Jandeleit-Dahm K. NADPH Oxidase –NOX5- Accelerates Renal Injury in Diabetic Nephropathy. Diabetes. 2017 Jul 26. pii: db161585. doi:10.2337/db16-1585. [Epub ahead of print]
  5. Ancona P, Eastwood GM, Lucchetta L, Ekinci EI, Bellomo R, Mårtensson J. The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc. 2017 Jun 1;19:167-74.
  6. Mårtensson J, Bailey M, Venkatesh B, Pilcher D, Deane A, Abdelhamid YA, Crisman M, Verma B, MacIsaac C, Wigmore G, Shehabi Y. Intensity of early correction of hyperglycaemia and outcome of critically ill patients with diabetic ketoacidosis. Critical care and resuscitation: journal of the Australasian Academy of Critical Care Medicine. 2017 Sep;19(3):266.
  7. Barr E, Barzi F, Hughes JT, Jerums G, O'Dea K, Brown A, Ekinci EI, Jones GR, Lawton PD, Sinha A, MacIsaac RJ. The contribution of cardio‐metabolic risk factors to estimated glomerular filtration rate (eGFR) decline in Indigenous Australians with and without albuminuria–the eGFR follow‐up study. Nephrology. 2017 May 14.
  8. Hall V, Kwong J, Johnson D, Ekinci EI. Caution advised with dapagliflozin in the setting of male urinary tract outlet obstruction. BMJ Case Reports. 2017 May 22;2017:bcr-2017.
  9. MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World journal of diabetes. 2017 May 15;8(5):172.
  10. Tran TT, Pease A, Wood AJ, Zajac JD, Mårtensson J, Bellomo R, Ekinci EI. Review of evidence for adult diabetic ketoacidosis management protocols. Frontiers in endocrinology. 2017 Jun 13;8:106.
  11. Patel SK, Restrepo C, Werden E, Churilov L, Ekinci E I, Srivastava PM, Ramchand J, Wai B, Chambers B, O’Callaghan CJ, Darby D. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study. BMC Endocrine Disorders 2017; 17(1):1-9 PMID: 28388897 DOI: 10.1186/s12902-017-0173-7
  12. Naidu P, Churilov L, Kong A, Kanaan R, Wong H, Van Mourik A, Yao A, Cornish E, Hachem M, Hart G K, Owen-Jones E, Robbins R, Lam Q, Samaras K, Zajac JD, Ekinci E I. Using routine HbA1c testing to determine the glycaemic status in psychiatric inpatients.  Frontiers in Endocrinology  2017; 8(53):1-8 PMID: 28396652 DOI: 10.3389/fendo.2017.00053P7
  13. Borschmann KN, Ekinci E I, Iuliano S, Churilov L, Pang MY, Bernhardt J. Reducing sedentary time and fat mass may improve glucose tolerance and insulin sensitivity in adults surviving 6 months after stroke: A phase I pilot study. European Stroke Journal 2017: 1-10 DOI: 10.1177/2396987317694469
  14. Ekinci EI, Torkamani N, Ramchand SK, Churilov L, Sikaris KA, Lu ZX, Houlihan C A.  Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy.  Journal of Diabetes Investigation  2017 ePub ahead of print 1-4  PMID: 28129477  DOI: 10.1111/jdi.12634.
  15. Ekinci E I, Kong A, Churilov L, Nanayakkara N, Chiu WL, Sumithran P, Premaratne E, Djukiadmodjo F, Owen-Jones E, Hart GK, Robbins R, Hardidge A, Johnson D, Baker ST, Zajac JD.  Using automated HbA1c testing to detect diabetes mellitus in orthopedic inpatients and its effect on outcomes.  PlosOne  2017; 12 (2):  e0168471-e0168497    PMID: 28192506  DOI: 10.1371/journal.pone.0172380
  16. Tint AN, Hoermann R, Wong H, Ekinci E I, MacIsaac RJ, Jerums G, Zajac JD, Grossmann M.  Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus.  European Journal of Endocrinology  2016; 174(1): 59-68   PMID: 26483395  DOI: 10.1530/EJE-15-0672
  17. Flynn E, Baqar S, Liu D, Ekinci E I, Farrell S, Zajac JD, De Luise M, Seeman E.  Bowel perforation complicating an ACTH secreting phaeochromocytoma.  Endocrinology, Diabetes and Metabolism Case Reports  2016;16: 0061     PMID: 28203371  DOI:10.1530/EDM-16-0061
  18. Barr E, Maple-Brown L, Barzi F, Hughes JT, Jerums G, Ekinci E I, Ellis A G, Jones G RD,  Lawton P D, Sajiv C, Majoni S W, Brown A DH, Hoy W E, O'Dea K, Cass A, MacIsaac R J.  Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: the eGFR Study.  Clinical Biochemistry  2016;16:1-8      PMID: 27894952  DOI:10.1016/j.clinbiochem.2016.11.024
  19. Coughlan MT, Higgins GC, Nguyen TV, Penfold S, Thallas-Bonke V, Ramm G, Van Bergen N, Henstridge DC, Sourris K, Harcourt B, Trounce I, Robb P, Laskowski A, McGee S, Genders A, Walder K, Drew B, Gregorevic P, Qian H, Thomas M, Jerums G, MacIsaac R J, Skene A, Power D, Ekinci E I, Wijeyeratne X, Gallo L, Herman-Edelstein M, Ryan M, Cooper M, Thorburn D, Forbes J.  Deficiency in apoptosis inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis.  Diabetes 2016; 65(4): 1085-1098   PMID: 26822084  DOI:10.2337/db15-0864.
  20. Di Muzio F, Presello B, Glassford NJ, Tsuji IY, Eastwood GM, Deane AM, Ekinci E I, Bellomo R, Martensson J.  Liberal versus conventional glucose targets in critically ill diabetic patients: a safety vanguard cohort assessment.  Critical Care Medicine  2016; 44(9):1683-1691   PMID: 27046086  DOI: /10.1097/CCM.0000000000001742
  21. Sourris KC, Yao H, Jerums G, Cooper ME, Ekinci E I, Coughlan MT.  Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events In Diabetic Nephropathy?  Current Drug Targets 2016;17(11):1252-1264 PMID:26201485 DOI: 10.2174/1389450116666150722141418
  22. MacIsaac RJ, Jerums G, Ekinci E I.  Cardio-renal protection with empagliflozin.  Annals of Translational Medicine  2016;44(20):409-4013  PMID: 27867961 DOI:10.21037/atm.2016.10.36
  23. Radcliffe NJ ,Seah J, Clarke M, MacIsaac RJ, Jerums G, Ekinci E I. Clinical Predictive Factors in Diabetic Kidney Disease Progression.  Journal of Diabetes Investigation 2016; 8(1): 6-18   PMID:27181363 DOI: 10.1111/jdi.12533.
  24. Kong YW, Baqar S, Jerums G, Ekinci E I. Sodium and its role in cardiovascular disease - the debate continues. Frontiers in Endocrinology 2016;7:1-17 PMID:28066329 DOI:10.3389/fendo.2016.00164
  25. Thomson HJ*, Ekinci E I*, Radcliffe NJ, Seah J, MacIsaac RJ, Jerums G, Premaratne E. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes.  Journal of Diabetes and Its Complications  2015; 30(2): 256-261   PMID: 26794645  DOI: 10.1016/j.jdiacomp.2015.11.003 *equal first author contribution
  26. Wood A J, Churilov L, Perera N, Thomas D, Poon A, MacIsaac R J, Jerums G, Ekinci E I. Estimating Glomerular Filtration Rate: Performance of the CKD-EPI Equation over time in Patients with Type 2 Diabetes.  Journal of Diabetes and Its Complications  2015; 30(1): 49-54   PMID: 26597601  DOI:10.1016/j.jdiacomp.2015.08.025
  27. Ekinci E I, Hughes J T, Chatfield M D, Lawton P D, Jones G RD, Ellis A G, Cass A, Thomas M, MacIsaac R J, O'Dea K, Jerums G, Maple-Brown L J.  Hyperfiltration in Indigenous Australians with and without diabetes.  Nephrology Dialysis Transplant  2015; 30(11):1877-1884   PMID: 26152395  DOI: 10.1093/ndt/gfv230
  28. Nanayakkara N, Nguyen H, Churilov L, Kong A, Pang N, Hart GK, Owen-Jones E, White J, Ross J, Stevenson V, Bellomo R, Lam Q, Crinis N, Robbins R, Johnson D, Baker ST, Zajac JD*, Ekinci EI*. Inpatient HbA1c testing: a prospective observational study.  BMJ Open Diabetes Research & Care  2015; 3(1): e000113-e000120   PMID: 26380095  DOI:10.1136/bmjdrc-2015-000113 * equal contribution
  29. Chen A X, Jerums G, Baqar S, Lambert E, Somarajah G, Thomas G, O’Callaghan C,  MacIsaac R J, Ekinci E I. Short –term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.  Clinical Science  2015; 129(5):415-422   PMID: 25849646  DOI: 10. 1042/CS20140536
  30. MacIsaac RJ, Ekinci E I, Premaratne E, Lu ZX, Seah J-m, Li Y, Boston R, Ward GM, Jerums G.  The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function.  BMC Nephrology 2015;16(1): 1-13   PMID: 26630928  DOI: 10.1186/s12882-015-0196-0
  31. Jerums G, Panagiotopoulos S, Ekinci E I, MacIsaac RJ.  Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: An analysis of interventional trials.  Journal of Human Hypertension  2015; 29(8): 473 - 477   PMID: 25608943  DOI: 10.1038/jhh.2014.117
  32. Farag M, Theverkalam G, Ekinci EI, Jerums G, MacIsaac RJ.  Soluble Tnf Receptors: A Biomarker for Diabetic Kidney Disease?  JSM Biomarkers  2015; 2(1): 1007-1010.
  33. Premaratne E, Verma S, Ekinci EI, Theverkalam G, Jerums G, MacIsaac RJ.  The impact of hyperfiltration on the diabetic kidney.  Diabetes Metabolism 2015; 41(1): 5-17 PMID: 25457474
  34. Watts A, Dwyer K, Ekinci E I, Jerums G, MacIsaac R J.  The shifting paradigm of albuminuria in diabetic kidney disease.  Medicine Today  2015;16(7):34-38
  35. Ekinci E I*, Chiu WL*, Lu ZX, Sikaris K, Churilov L, Bittar I, Lam Q, Crinis N, Houlihan C A. A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing.  Clinical Endocrinology  2014; 82(4): 604-610   PMID: 25079145  DOI: 10.1111/cen.12571*equal first author contribution
  36. Hiscock H, Ledgerwood K, Danchin M, Ekinci E I, Johnson E, Wilson A  Clinical Research Potential in Victorian Hospitals: the Victorian Clinician Researcher Needs Analysis Survey.  Internal Medicine Journal  2014; 44(5):477-482   PMID: 24612186  DOI:10.1111/imj.12396
  37. Page M*, Ekinci E I*, Jones R, Gow P, Angus P, O’Brien R. Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.  Internal Medicine Journal  2014;44(6): 601-604   PMID: 24946816 DOI:10.1111/imj.12444 *equal first author contribution
  38. Libianto R, Jerums G, Lam W, Chen AX, Baqar S, Pyrlis F, MacIsaac R J, Moran J, Ekinci E I. Relationship between serum aldosterone levels and urinary sodium excretion in patients with diabetes in the presence and absence of renin angiotensin aldosterone blockade.  Clinical Science  2014;126(2):147-154   PMID: 23875766  DOI: 10.1042/CS20130128
  39. Bach L A, Ekinci E I, Engler D, Gilfillan C, Hamblin P S, MacIsaac R J, Soldatos G, Steele C, Ward G M, Wyatt S.  The high burden of inpatient diabetes mellitus: The Melbourne Public Hospitals Diabetes Inpatient Audit.  Medical Journal of Australia  2014; 201(6): 334-338   PMID: 25222457 DOI: 10.5694/mja13.00104
  40. Maple-Brown L J, Ekinci E I, Hughes J T, Chatfield M, Lawton P D, Jones G RD, Ellis A G, Sinha A, Cass A, Hoy W E, O'Dea K, Jerums G, MacIsaac RJ. The performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD- EPI) and Modification of Diet in Renal Disease (MDRD) formulas for estimating Glomerular Filtration Rate (eGFR) in Indigenous Australians with and without diabetes.  Diabetic Medicine  2014;31(7):829-838
  41. Teng J, See E, Hill P, Ekinci E I, Jerums G, Dwyer K, MacIsaac R J.  The spectrum of renal disease in people with diabetes.  Nephrology (Carlton) 2014; 19(9): 528-536   PMID: 24899354  DOI: 10.1111/nep.12288
  42. Theverkalam G, O’Neal D N, Ward G M, Jerums G, Ekinci E I, MacIsaac R J. Management of treatment resistant hypertension in diabetes.  Diabetes Management Journal  2014
  43. MacIsaac R J, Ekinci E I, Jerums G.  Markers and risk factors for the development and progression of diabetic nephropathy.  American Journal of Kidney Diseases 2014; 63:2(S2): S39 - S62   PMID: 24461729  DOI:10.1053/j.ajkd.2013.10.048
  44. MacIsaac R J, Ekinci E I, Jerums G.  Progressive Diabetic Nephropathy. How Useful is Microalbuminuria?  Kidney International  2014; 86(1): 50-57  PMID: 24717301  DOI:10.1038/ki.2014.98
  45. Seah J, Yao H, MacIsaac RJ, Ekinci EI, Jerums G.  Reducing the complications of type 2 diabetes: challenges in individualising care.  Medicine Today  2014; 15(3): 37-47 [
  46. Borschmann K, Pang M YC , Iuliano-Burns S, Brodtmann A, Ekinci E I , Bernhardt J.  Changes to volumetric bone mineral density and structure after stroke: a prospective study.  International Journal of Stroke  2013;10(3):396-399   PMID: 24373530  DOI: 10.1111/ijs.12228
  47. Ekinci E I, Lu Z X,  Bittar I, Cheong K, Lam Q, Crinis N, Sikaris K, Houlihan C A. Longitudinal Assessment of Thyroid Function in Pregnancy.  Annals of Clinical Biochemistry  2013; 50(6):595-602   PMID: 23873872  DOI:10.1177/0004563213486450
  48. Baqar S, Zajac JD, Ekinci E I. Physicians as Medical Experts Oral Abstracts.  Internal Medicine Journal  2013; 43(7):7 - 20     DOI: 10.1111/imj.12149
  49. Ekinci E I, Jerums G, Skene A,  Dayan S, Power D, Panagiotopoulos S,  McNeil K, Clarke S, Levidiotis V, Baker S, Fioretto P, MacIsaac RJ.  Renal structural changes in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function.  Diabetes Care 2013; 36(11): 3620-3626   PMID: 23835690  DOI: 10.2337/dc12-2572
  50. MacIsaac RJ, Ekinci EI, Jerums G.  Renal Disease in diabetes: when to investigate for causes other than diabetes.  Endocrinology Today  2013; 2: 22-26
  51. MacIsaac RJ, Ekinci EI, Jerums G.  The importance of glycaemic control in slowing the progression of diabetic kidney disease.  Diabetes Management Journal  2013; 42: 32-33
  52. MacIsaac, Ekinci EI, Jerums G.  When Measuring Blood Pressure at home is useful.  Diabetes Management Journal  2013;42:10-11
  53. Jerums G, Ekinci E I, Panagiotopoulos S, MacIsaac R J.  Early GFR loss as a marker of diabetic nephropathy. European Nephrology 2012;6(1):27-31 DOI:10.17925/EE.2012.08.01.27
  54. MacIsaac RJ, Ekinci EI, Kelly D J, Jerums G  New treatments of diabetic chronic kidney disease.  Journal of Nephrology and Therapeutics 2012;2:2161-0959  DOI:10.4172/2161-0959.S2-006
  55. Ekinci E I, Clarke S, Thomas M C, Moran J L, Cheong K, MacIsaac R J, Jerums G.  Dietary salt intake and mortality in patients with type 2 diabetes.  Diabetes Care  2011; 34(3): 703-709   PMID: 21289228  DOI: 10.2337/dc10-1723
  56. Ekinci E I, Cheong K Y, Dobson M, Premaratne E, Finch S, MacIsaac R J, Jerums G. High sodium and low potassium intake in patients with Type 2 diabetes. Diabetic Medicine 2010;27(12): 1401-1408 PMID: 21059093 DOI: 10.1111/j.1464-5491.2010.03111.x
  57. Yip G, Ekinci E I, Lee S T, Jerums G, Grossmann M.  Carbimazole-induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role?  Internal Medicine Journal  2010; 40(4): 300-303   PMID: 20529040  DOI: 10.1111/j.1445-5994.2009.02143.x. [YG=Clin, 50%, R, Int].
  58. Ekinci EI, Cheong K, Dobson M, Premaratne E, Finch S, MacIsaac R, Jerums G.  High sodium and low potassium intake in patients with Type 2 diabetes.  Diabetic Medicine  2010; 27(12):1401-1408   PMID: 21059093  DOI:10.1111/j.1464-5491.2010.03111.x. [JG=S, 90%, R, Int].
  59. Ekinci E I, Thomas G, MacIsaac R, Johnson C, houlihan C, Panagiotopoulos S, Premaratne E, Hao H, Finch S, O'Callaghan C, Jerums G.  Salt supplementation blunts the blood pressure response to telmisartan hydrochlorothiazide in hypertensive patients with type 2 diabetes.  Diabetologia*  2010; 53(7):1295 - 1303   PMID: 20372874  DOI:10.1007/s00125-010-1711-2 [JG=S, 80%, R, Int].  *a leading diabetes journal.
  60. Ekinci E I, Thomas G, Thomas D, MacIsaac R, Houlihan C, Finch S, Panagiotopoulos S, O'Callaghan C, Jerums G.  Effects of salt supplementation on the albuminuric response to telmisartan - hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.  Diabetes Care*  2009; 32(8): 1398-13402   PMID: 19549737  DOI: 10.2337/dc08-2297 [JG=S, 80%,  R, Int].   *a leading clinical diabetes journal
  61. Premaratne E, MacIsaac R, Finch S, Panagiotopoulos S, Ekinci EI, Jerums G.  Serial measurements of cystatin C are more accurate than creatinine based methods in detecting declining renal function in type 1 diabetes.  Diabetes Care  2008; 31(5): 971-973   PMID: 18319326  DOI:10.2337/dc07-1588.
  62. Iser D, Ekinci EI, Baichi MM, Arifuddin RM, Maliakkal BJ.  Complications of colonoscopy.  Journal of Gastroenterology and Hepatology  2005; 20(8):1301-1301   PMID: 16048583  DOI: 10.1111/j.1440-1746.2005.04054.x.].
  63. Ekinci EI, Donnan GA.  The neurological manifestations of cardiac myxoma; a review of literature and report cases.  The Internal Medicine Journal  2004; 34(5): 243-249   PMID: 15151670  DOI: 10.1111/j.1444-0903.2004.00563.x.


  1. Jerums G, Ekinci E I, Premaratne E, Baker S T, Panagiotopoulos S, MacIsaac R J: Diabetic nephropathy. Edited by DeFronzo R A, Ferrannini E, Alberti KGMM, Zimmet P. John Wiley & Sons, London, 2014, p. International Textbook of Diabetes Mellitus, Wiley-Blackwell Chapter 71, Diabetic Nephropathy, Section 11: Complications of diabetes: General and Microvascular
  2. Ekinci, EI. “June Howqua: Resilient, persistent and decisive, MBBS 1944” in Strength of Mind edited by Jacqueline Healy, 2013, Published by Medical History Museum, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne

Letters to the Editor

  1. Ekinci E I, Moran J L, Thomas M C, Cheong K, Clarke S, Chen A, Dobson M, Leong A, MacIsaac R J, Jerums G.  Relationship between urinary sodium excretion over time and mortality in type 2 diabetes.  Diabetes Care 2014;37(4): e62 - e63   PMID: 24652730  DOI:10.2337/dc13-1947
  2. Ekinci E I, MacIsaac R J, Thomas M C, Jerums G.  Response to comment on: Ekinci et al. Dietary salt intake and mortality in patients with type 2 diabetes.  Diabetes Care 2011; 34: 703 - 709   PMID: 21709290  DOI: 10.2337/dc11-0834


  1. Ekinci, E I, Where East Meets West, 2000: UMMS Peter G Jones Elective Essay Prize 2000, Chiron 2001 (Annual Journal of the University of Melbourne Medical Society)

Research Projects

Faculty Research Themes

Infection and Immunology

School Research Themes


Key Contact

For further information about this research, please contact Associate Professor Elif Ekinci

Department / Centre


Unit / Centre

MDHS Research library
Explore by researcher, school, project or topic.